Pain News and Research

Latest Pain News and Research

FDA to stop the marketing of unapproved injectable colchicine

The U.S. Food and Drug Administration has announced its intention to take enforcement action against companies marketing unapproved injectable colchicine, a drug used to treat gout.

7 Feb 2008

Brain disturbances in chronic pain

People with unrelenting pain don't only suffer from the non-stop sensation of throbbing pain.

7 Feb 2008

Taking more than one NSAID may lead to complications

Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to treat arthritis, which affects one-third of all adults.

5 Feb 2008

Enbrel shown to significantly reduced levels of C-reactive protein

Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. Median reduction in CRP levels was 10 times greater in the ENBREL treated group compared to the placebo treated group.

5 Feb 2008

Participants recruited for VCU study on premenstrual dysphoric disorder

The Virginia Commonwealth University Mood Disorders Institute is recruiting participants for a national study of a new treatment method for premenstrual dysphoric disorder, a severe and debilitating form of premenstrual syndrome, or PMS.

4 Feb 2008

Reducing pain could lead to increased immunization rates

Studies have shown that some parents are reluctant to have their children immunized because they fear their children will experience significant pain during and after the injections.

4 Feb 2008

FDA approves only once-daily inhaled corticosteroid for children

Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) has approved ASMANEX TWISTHALER 110 mcg (mometasone furoate inhalation powder) for the maintenance treatment of asthma as a preventive therapy in patients 4 to 11 years of age.

4 Feb 2008

Novel treatment for blood clots in the legs appears to be safe and effective

The study found that injecting or “lacing” the clot with a fiber-binding thrombolytic agent effectively treats deep vein thrombosis (DVT) and reduces the risk of subsequent recurrence or bleeding.

4 Feb 2008

Trabectome procedure for glaucoma

Glaucoma is a devastating disease that harms the eye without manifesting early signs or symptoms.

4 Feb 2008

Porous structures help boost integration of host tissue with implants

Results published in FASEB (the journal of the Federation of American Societies for Experimental Biology) by researchers at Columbia University, including Jeremy Mao of the Columbia College of Dental Medicine, demonstrate a novel way of using porous structures as a drug-delivery vehicle that can help boost the integration of host tissue with surgically implanted titanium.

4 Feb 2008

Why is scratching so nice?

In the first study to use imaging technology to see what goes on in the brain when we scratch, researchers at Wake Forest University Baptist Medical Center have uncovered new clues about why scratching may be so relieving - and why it can be hard to stop. The work is reported online in the Journal of Investigative Dermatology and will appear in a future print issue.

31 Jan 2008

Allergies linked to irritable bowel syndrome

Adults with allergy symptoms report a high incidence of Irritable Bowel Syndrome (IBS), suggesting a link between atopic disorders and IBS according to a study published on January in Annals of Allergy, Asthma & Immunology, the scientific journal of the American Collegeof Allergy, Asthma and Immunology.

31 Jan 2008

New therapy for blood clots in the legs appears to be safe and effective

A novel treatment for blood clots in the legs appears to be safe and effective, according to a pilot study published in the February issue of Radiology.

30 Jan 2008

Antidepressants might be worthless for treating low back pain

The review appears in the latest issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

30 Jan 2008

Celebrex may disrupt heart rhythm

Celebrex, a popular arthritis drug that blocks pain by inhibiting an enzyme known as COX-2, has been shown in laboratory studies to induce arrhythmia, or irregular beating of the heart, via a novel pathway unrelated to its COX-2 inhibition.

25 Jan 2008

M. D. Anderson, AstraZeneca form alliance to advance understanding of cancer-related pain

The University of Texas M. D. Anderson Cancer Center and AstraZeneca (NYSE:AZN) today announced that they will collaborate to help advance understanding of neuropathic pain caused by cancer chemotherapy, a side effect that often limits optimal therapeutic dosing in cancer treatments.

25 Jan 2008